Skip to main content
See the bias in every story

CDC Tracks Highly Mutated BA.3.2 COVID Variant in 25 US States

United States

PATRICK T. FALLON/AFP via Getty Images/Getty

PATRICK T. FALLON/AFP via Getty Images/Getty

What Happened

CDC is tracking BA.3.2 after surveillance found it in nasal swabs, traveler tests and 132 wastewater samples across 25 U.S. states. Lab studies show about 70–75 spike mutations and reduced antibody neutralization, but agencies report no evidence so far of greater severity, and the CDC is monitoring spread.

Why It Matters

BA.3.2’s heavy spike mutations and lab findings of reduced antibody neutralization mean current vaccines may be less effective at preventing infections, potentially increasing transmission and social strain on U.S. public-health systems and on older adults and immunocompromised people. Over the coming months this could raise hospital pressure and prompt updated vaccine formulations or renewed mitigation measures.

What Happened

CDC is tracking BA.3.2 after surveillance found it in nasal swabs, traveler tests and 132 wastewater samples across 25 U.S. states. Lab studies show about 70–75 spike mutations and reduced antibody neutralization, but agencies report no evidence so far of greater severity, and the CDC is monitoring spread.

Why It Matters

BA.3.2’s heavy spike mutations and lab findings of reduced antibody neutralization mean current vaccines may be less effective at preventing infections, potentially increasing transmission and social strain on U.S. public-health systems and on older adults and immunocompromised people. Over the coming months this could raise hospital pressure and prompt updated vaccine formulations or renewed mitigation measures.

Where Sources Agree

  • arrows_inputUS Variant Detection Confirmed: Sources align on the BA.3.2 variant's detection in 25 U.S. states, noting its initial identification in the U.S. occurred in June 2025, according to CDC and WHO reports.
  • arrows_inputNew Variant Evades Immunity: Sources across outlets confirm the BA.3.2 Omicron descendant carries 70 to 75 genetic changes in its spike protein, which may reduce protection from current vaccines targeting JN.1 subvariants, according to CDC analysis and laboratory studies.
  • arrows_inputBA.3.2 Severity Unchanged: Predominant reporting shows the BA.3.2 variant causes symptoms similar to other Omicron strains and does not appear to cause more severe illness; all hospitalized patients with the variant survived, according to CDC analysis and reported cases.

Where Sources Disagree

  • arrows_outputBA.3.2 Threat Assessment: Some sources indicate the BA.3.2 variant is not currently dominant or causing more severe illness. However, other sources suggest its mutations carry high risk potential and could drive a summer surge.
  • arrows_outputBA.3.2 Vaccine Effectiveness: Some health organizations expect current vaccines to protect against severe disease from the BA.3.2 variant. However, other researchers suggest current vaccines may not protect against infection or evade immunity.

Timeline

March 19, 2026

CDC tracking and recent data: The CDC reported on March 19, 2026 that it was tracking BA.3.2 after routine surveillance detected a steady rise in U.S. cases, while WasteWaterSCAN data showed BA.3.2 in 3.7% of wastewater samples as of March 14, 2026, reflecting active monitoring and mixed signals about prevalence.

February 11, 2026

Widespread U.S. detections: By February 11, 2026, CDC data showed BA.3.2 present in clinical samples from five patients, nasal swabs from four travelers, three airplane wastewater samples and 132 wastewater samples across 25 U.S. states, indicating broader circulation than clinical sequencing alone revealed.

December 5, 2025

WHO monitoring, lab concerns: The World Health Organization designated BA.3.2 a Variant Under Monitoring on December 5, 2025, while lab studies found roughly 70–75 spike protein mutations and reduced antibody neutralization by the 2025–2026 LP.8.1-adapted mRNA vaccine in laboratory tests. These findings raised concern about potential immune evasion and the need for more data on vaccine effectiveness.

Summary by Ground AI

Sources

See All 60

A varied selection of sources chosen by Ground to reflect the diversity of this story’s coverage.

View All Sources

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal